1. Intraductal carcinoma of the prostate in the absence of high‐grade invasive carcinoma represents a molecularly distinct type of in situ carcinoma enriched with oncogenic driver mutations. Issue 1 (24th May 2019) Authors: Khani, Francesca; Wobker, Sara E; Hicks, Jessica L; Robinson, Brian D; Barbieri, Christopher E; De Marzo, Angelo M; Epstein, Jonathan I; Pritchard, Colin C; Lotan, Tamara L Journal: Journal of pathology Issue: Volume 249:Issue 1(2019) Page Start: 79 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Re: Stoehr et al. Lack of evidence for frequent MED12 p.L1224F mutation in prostate tumours from Caucasian patients. J Pathol 2013; 230: 453–456. Issue 2 (10th September 2013) Authors: Barbieri, Christopher E; Sboner, Andrea; Rubin, Mark A; Garraway, Levi A Journal: Journal of pathology Issue: Volume 231:Issue 2(2013) Page Start: 271 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗